Skip to content

Prevalence and Profile of Aspirin Resistance in Hemodialysis Patients

Prevalence of Aspirin Resistance in Hemodialysis Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00792272
Enrollment
100
Registered
2008-11-17
Start date
2008-06-30
Completion date
2008-11-30
Last updated
2013-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aspirin Resistance

Keywords

aspirin resistance, aspirin resistance in hemodialysis patients

Brief summary

Dialysis patient could be more aspirin resistant than the general population based on data from chronic kidney disease patients

Detailed description

We will try to describe the profile of aspirin resistant patient in hemodialysis patients

Interventions

None listed

Sponsors

Staten Island University Hospital
CollaboratorOTHER
Northwell Health
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* all hemodialysis patients on aspirin

Exclusion criteria

* low platelets \<100.000 * coagulopathy, bleeding disorders * patient on plavix

Design outcomes

Primary

MeasureTime frame
Aspirin Resistance in Hemodialysis patients2 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026